中国皮肤性病学杂志
中國皮膚性病學雜誌
중국피부성병학잡지
THE CHINESE JOURNAL OF DERMATOVENEREOLOGY
2001年
2期
137-138
,共2页
周群%吴跃申%徐琴言%陈葛裙%何芳德
週群%吳躍申%徐琴言%陳葛裙%何芳德
주군%오약신%서금언%진갈군%하방덕
皮炎%湿疹%派瑞松霜
皮炎%濕疹%派瑞鬆霜
피염%습진%파서송상
目的观察派瑞松霜治疗皮炎湿疹的疗效、耐受性及不良反应。方法 60例患者来自门诊和住院病人,男55例,女5例。年龄14~87岁,平均71.1±15.1岁;病程2天~20年,平均9.5±25.1月。每日2次外用派瑞松霜涂于患处,每周随访1次,共3周。结果治愈33例(55.0%),显效16例(26.7%),好转4例(6.6%),无效7例(11.7%)。总有效率为81.7%,未发现不良反应。结论派瑞松霜是治疗皮炎湿疹类皮肤病的安全、有效药物。
目的觀察派瑞鬆霜治療皮炎濕疹的療效、耐受性及不良反應。方法 60例患者來自門診和住院病人,男55例,女5例。年齡14~87歲,平均71.1±15.1歲;病程2天~20年,平均9.5±25.1月。每日2次外用派瑞鬆霜塗于患處,每週隨訪1次,共3週。結果治愈33例(55.0%),顯效16例(26.7%),好轉4例(6.6%),無效7例(11.7%)。總有效率為81.7%,未髮現不良反應。結論派瑞鬆霜是治療皮炎濕疹類皮膚病的安全、有效藥物。
목적관찰파서송상치료피염습진적료효、내수성급불량반응。방법 60례환자래자문진화주원병인,남55례,녀5례。년령14~87세,평균71.1±15.1세;병정2천~20년,평균9.5±25.1월。매일2차외용파서송상도우환처,매주수방1차,공3주。결과치유33례(55.0%),현효16례(26.7%),호전4례(6.6%),무효7례(11.7%)。총유효솔위81.7%,미발현불량반응。결론파서송상시치료피염습진류피부병적안전、유효약물。
Objective To observe the effect and safety to Pevisone cream on patients with dermatitis and eczema. Methods Sixty cases from the clinic and inpatient were treated with Pevisone cream twice a day followed-up once a week and ended in the three weeks. Results 33 cases(55% ) were cured,all effective rate was up to 81.7%. No one had side-effect. Conclusion Pevisone cream is effective, safe remedy to patients with dermatitis and eczema, especially for basic clinic and hospital.